- Home
- HAS vs ASND Comparison
HAS vs ASND Comparison
Compare HAS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- ASND
- Stock Information
- Founded
- HAS 1923
- ASND 2006
- Country
- HAS United States
- ASND Denmark
- Employees
- HAS N/A
- ASND N/A
- Industry
- HAS Recreational Games/Products/Toys
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- HAS Consumer Discretionary
- ASND Health Care
- Exchange
- HAS Nasdaq
- ASND Nasdaq
- Market Cap
- HAS 9.6B
- ASND 10.6B
- IPO Year
- HAS N/A
- ASND 2015
- Fundamental
- Price
- HAS $73.82
- ASND $170.86
- Analyst Decision
- HAS Strong Buy
- ASND Strong Buy
- Analyst Count
- HAS 9
- ASND 16
- Target Price
- HAS $80.22
- ASND $218.19
- AVG Volume (30 Days)
- HAS 2.0M
- ASND 435.4K
- Earning Date
- HAS 07-24-2025
- ASND 05-01-2025
- Dividend Yield
- HAS 3.80%
- ASND N/A
- EPS Growth
- HAS N/A
- ASND N/A
- EPS
- HAS 3.03
- ASND N/A
- Revenue
- HAS $4,265,300,000.00
- ASND $398,509,511.00
- Revenue This Year
- HAS $3.16
- ASND $75.05
- Revenue Next Year
- HAS $4.15
- ASND $78.14
- P/E Ratio
- HAS $24.35
- ASND N/A
- Revenue Growth
- HAS N/A
- ASND 12.06
- 52 Week Low
- HAS $49.00
- ASND $111.09
- 52 Week High
- HAS $73.94
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- HAS 69.48
- ASND 52.37
- Support Level
- HAS $67.11
- ASND $166.84
- Resistance Level
- HAS $73.02
- ASND $180.78
- Average True Range (ATR)
- HAS 1.59
- ASND 5.57
- MACD
- HAS 0.34
- ASND -0.53
- Stochastic Oscillator
- HAS 97.81
- ASND 38.59
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.